Table 4.
A. Symptoms in long-COVID-19 cohort ≥ 90 days. B. Persistent symptoms summarized per category in long-COVID cohort.
| A | Number (Total) | % | Group A | % | Group B | % | Group C | % | Group D | % | Group E | % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SOB/SOBOE | 17 | 27.419 | 7 | 28 | 2 | 15.385 | 2 | 50 | 1 | 11.11 | 5 | 50 |
| Runny Nose/Congestion | 7 | 11.290 | 4 | 16 | 1 | 7.692 | 0 | 0 | 1 | 11.11 | 1 | 10 |
| Sore Throat | 3 | 4.839 | 1 | 4 | 2 | 15.385 | 0 | 0 | 0 | 0.00 | 0 | 0 |
| Dysphagia/Difficulty Swallowing | 2 | 3.226 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 2 | 20 |
| Cough | 7 | 11.290 | 3 | 12 | 2 | 15.385 | 0 | 0 | 0 | 0.00 | 2 | 20 |
| Wheezing | 2 | 3.226 | 1 | 4 | 0 | 0 | 0 | 0 | 0 | 0.00 | 1 | 10 |
| Dyspnea/DOE | 12 | 19.355 | 5 | 20 | 1 | 7.692 | 1 | 25 | 1 | 11.11 | 4 | 40 |
| Sputum | 6 | 9.677 | 2 | 8 | 0 | 0 | 1 | 25 | 1 | 11.11 | 2 | 20 |
| Chest Pain/Tightness/Heaviness | 15 | 24.194 | 4 | 16 | 5 | 38.462 | 0 | 0 | 2 | 22.22 | 4 | 40 |
| Tachycardia/Palpitations | 4 | 6.452 | 2 | 8 | 0 | 0 | 0 | 0 | 1 | 11.11 | 1 | 10 |
| Fatigue/Weakness/Tiredness | 31 | 50.000 | 11 | 44 | 8 | 61.538 | 3 | 75 | 5 | 55.56 | 4 | 40 |
| Hair Loss/Thinning | 22 | 35.484 | 7 | 28 | 4 | 30.769 | 1 | 25 | 5 | 55.56 | 5 | 50 |
| Muscle Weakness | 8 | 12.903 | 1 | 4 | 2 | 15.385 | 0 | 0 | 2 | 22.22 | 3 | 30 |
| Myalgia | 7 | 11.290 | 1 | 4 | 2 | 15.385 | 1 | 25 | 1 | 11.11 | 2 | 20 |
| Arthralgia | 6 | 9.677 | 1 | 4 | 3 | 23.077 | 1 | 25 | 0 | 0.00 | 1 | 10 |
| Abdominal Pain/Nausea/Bowel Movements | 4 | 6.452 | 1 | 4 | 2 | 15.385 | 0 | 0 | 0 | 0.00 | 1 | 10 |
| Rash/Dermatological Issues | 8 | 12.903 | 1 | 4 | 4 | 30.769 | 0 | 0 | 1 | 11.11 | 2 | 20 |
| Anosmia | 19 | 30.645 | 9 | 36 | 3 | 23.077 | 1 | 25 | 2 | 22.22 | 3 | 30 |
| Dysgeusia | 10 | 16.129 | 7 | 28 | 0 | 0 | 0 | 0 | 1 | 11.11 | 2 | 20 |
| Ear Pain/Hearing Issues | 4 | 6.452 | 1 | 4 | 4 | 30.769 | 0 | 0 | 0 | 0.00 | 0 | 0 |
| Headache/Head Heaviness | 12 | 19.355 | 3 | 12 | 4 | 30.769 | 1 | 25 | 0 | 0.00 | 4 | 40 |
| Brain Fog/Cognitive Issues | 14 | 22.581 | 2 | 8 | 4 | 30.769 | 2 | 50 | 1 | 11.11 | 5 | 50 |
| Anxiety/PTSD | 22 | 35.484 | 9 | 36 | 5 | 38.462 | 1 | 25 | 3 | 33.33 | 4 | 40 |
| Depression | 8 | 12.903 | 1 | 4 | 4 | 30.769 | 1 | 25 | 0 | 0.00 | 2 | 20 |
| Anorexia/Decrease in appetite | 3 | 4.839 | 0 | 0 | 2 | 15.385 | 0 | 0 | 1 | 11.11 | 0 | 0 |
| Insomnia | 14 | 22.581 | 4 | 16 | 2 | 15.385 | 1 | 25 | 3 | 33.33 | 4 | 40 |
| Adenopathy | 1 | 1.613 | 0 | 0 | 1 | 7.692 | 0 | 0 | 0 | 0.00 | 0 | 0 |
| Diplopia/Bilateral eye pain | 2 | 3.226 | 0 | 0 | 2 | 15.385 | 0 | 0 | 0 | 0.00 | 0 | 0 |
| Neurological Issues (Numbness/Tingling) | 3 | 4.839 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 3 | 30 |
| B | Number of Persistent Symptoms | |||||||||||
| Total (n = 61) |
Category A
(n = 25) |
Category B
(n = 13) |
Category C
(n = 4) |
Category D
(n = 9) |
Category E
(n = 10) |
|||||||
| Mean (SD) | 4.52 (3.08) | 3.52 (1.72) | 5.31 (3.95) | 4.25 (3.49) | 3.78 (2.25) | 6.8 (3.4) | ||||||
| Range | 1 to 14 | 1 to 7 | 1 to 14 | 1 to 10 | 1 to 7 | 2 to 11 | ||||||
| IQR | 4 | 3 | 3 | 3.75 | 4 | 6.75 | ||||||